Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  238.62
-5.57 (-2.28%)
AAPL  292.80
+2.25 (0.77%)
AMD  453.05
-22.45 (-4.72%)
BAC  55.01
+0.59 (1.07%)
GOOG  354.56
-7.73 (-2.13%)
META  576.08
-8.51 (-1.46%)
MSFT  401.81
-1.60 (-0.40%)
NVDA  202.43
-5.76 (-2.77%)
ORCL  203.70
-2.11 (-1.03%)
TSLA  383.83
-12.85 (-3.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.